Arrowhead Pharmaceuticals Inc
ARWRHealthcare|Biotechnology|USA
$59.50
-1.62 (-2.65%)
Tangible Book
$4.09
Graham Number
$11.87
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (179)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Hamilton James C | Chief Medical Officer | 2026-03-05 | SELL | 10,000 | $64.19 | $641.9K |
| Hamilton James C | Chief Medical Officer | 2026-01-05 | SELL | 40,164 | $63.11 | $2534.8K |
| O'Brien Patrick | COO | 2026-01-05 | SELL | 49,493 | $63.11 | $3123.5K |
| Anzalone Christopher Richard | CEO | 2026-01-02 | SELL | 13,187 | $66.1 | $871.7K |
| Anzalone Christopher Richard | CEO | 2025-12-29 | SELL | 51,726 | $69.13 | $3575.8K |
| Ferrari Mauro | Director | 2025-12-26 | SELL | 7,530 | $70 | $527.1K |
| Waddill William D. | Director | 2025-12-19 | SELL | 8,367 | $67.65 | $566K |
| Vakiener Victoria | Director | 2025-12-19 | SELL | 10,040 | $67.68 | $679.5K |
| OLUKOTUN ADEOYE Y | Director | 2025-12-19 | SELL | 10,000 | $67.66 | $676.6K |
| Anzalone Christopher Richard | CEO | 2025-12-17 | SELL | 85,000 | $64.04 | $5443.4K |
| Anzalone Christopher Richard | CEO | 2025-12-16 | SELL | 184,298 | $67 | $12348K |
| PERRY MICHAEL S | Director | 2025-12-05 | SELL | 16,250 | $61.03 | $991.7K |
| Ferrari Mauro | Director | 2025-11-28 | SELL | 8,750 | $56.39 | $493.4K |
| Hamilton James C | Chief Medical Officer | 2025-10-01 | SELL | 20,000 | $35 | $700K |
| Hamilton James C | Chief Medical Officer | 2025-09-12 | SELL | 15,000 | $30 | $450K |
| Hamilton James C | Chief Medical Officer | 2025-09-02 | SELL | 15,000 | $25 | $375K |
| Hamilton James C | Chief Medical Officer | 2025-08-15 | SELL | 10,000 | $20 | $200K |
| Anzalone Christopher Richard | CEO | 2025-04-11 | SELL | 141,122 | $10.87 | $1534K |
| Anzalone Christopher Richard | CEO | 2025-03-13 | SELL | 51,425 | $15.07 | $775K |
| Anzalone Christopher Richard | CEO | 2025-03-04 | SELL | 300,000 | $17.58 | $5274K |
| OLUKOTUN ADEOYE Y | Director | 2025-01-23 | SELL | 959 | $21 | $20.1K |
| O'Brien Patrick | COO and General Counsel | 2025-01-07 | SELL | 37,184 | $19.8 | $736.2K |
| Myszkowski Kenneth Allen | CFO | 2025-01-07 | SELL | 45,167 | $19.77 | $893K |
| Hamilton James C | Chief Discovery/Trans Medicine | 2025-01-06 | SELL | 32,729 | $19.82 | $648.7K |
| Anzalone Christopher Richard | CEO | 2025-01-02 | SELL | 11,520 | $19.05 | $219.5K |
| OLUKOTUN ADEOYE Y | Director | 2024-12-27 | SELL | 2,850 | $20 | $57K |
| Anzalone Christopher Richard | CEO | 2024-12-23 | SELL | 12,563 | $19.59 | $246.1K |
| Anzalone Christopher Richard | CEO | 2024-12-18 | SELL | 26,712 | $21.24 | $567.4K |
| Waddill William D. | Director | 2024-12-17 | SELL | 7,495 | $21.97 | $164.7K |
| GIVEN DOUGLAS B | Director | 2024-12-17 | SELL | 5,547 | $21.91 | $121.5K |
| Vakiener Victoria | Director | 2024-12-16 | SELL | 8,994 | $21.91 | $197.1K |
| Oliver Tracie | Chief Commercial Officer | 2024-07-02 | SELL | 9,394 | $25.28 | $237.5K |
| Vakiener Victoria | Director | 2024-05-02 | SELL | 1,799 | $23.31 | $41.9K |
| Hamilton James C | Chief Discovery/Trans Medicine | 2024-04-01 | SELL | 6,000 | $28.03 | $168.2K |
| Lu Hongbo | Director | 2024-03-20 | BUY | 3,000 | $27.66 | $83K |
| Myszkowski Kenneth Allen | CFO | 2024-03-06 | SELL | 40,000 | $35.19 | $1407.6K |
| Anzalone Christopher Richard | CEO | 2024-01-31 | SELL | 57,499 | $32.35 | $1860.1K |
| Hamilton James C | Chief Discovery/Trans Medicine | 2024-01-12 | SELL | 7,940 | $36.89 | $292.9K |
| GIVEN DOUGLAS B | Director | 2024-01-11 | SELL | 2,911 | $38.06 | $110.8K |
| Waddill William D. | Director | 2024-01-11 | SELL | 3,934 | $38.07 | $149.8K |
| Ferrari Mauro | Director | 2024-01-11 | SELL | 3,147 | $38.06 | $119.8K |
| Vakiener Victoria | Director | 2024-01-11 | SELL | 4,720 | $38.1 | $179.8K |
| Hamilton James C | Chief Discovery/Trans Medicine | 2024-01-05 | SELL | 38,443 | $34.69 | $1333.6K |
| O'Brien Patrick | COO and General Counsel | 2024-01-05 | SELL | 33,190 | $34.36 | $1140.4K |
| Oliver Tracie | Chief Commercial Officer | 2024-01-05 | SELL | 74 | $33.89 | $2.5K |
| Myszkowski Kenneth Allen | CFO | 2024-01-05 | SELL | 16,104 | $35.27 | $568K |
| San Martin Javier | Chief Medical Officer | 2024-01-05 | SELL | 8,303 | $35.26 | $292.8K |
| Anzalone Christopher Richard | CEO | 2024-01-02 | SELL | 9,952 | $31.01 | $308.6K |
| Anzalone Christopher Richard | CEO | 2023-12-20 | SELL | 12,000 | $28.54 | $342.5K |
| San Martin Javier | Chief Medical Officer | 2023-11-20 | SELL | 19,700 | $28.8 | $567.4K |
| Anzalone Christopher Richard | CEO | 2023-10-25 | SELL | 24,338 | $24.21 | $589.2K |
| Vakiener Victoria | Director | 2023-09-28 | SELL | 1,550 | $26.33 | $40.8K |
| Anzalone Christopher Richard | CEO | 2023-09-18 | SELL | 57,755 | $28.12 | $1624.1K |
| Oliver Tracie | Chief Commercial Officer | 2023-07-03 | SELL | 8,925 | $35.31 | $315.1K |
| Hamilton James C | Chief Discovery/Trans Medicine | 2023-06-30 | SELL | 3,000 | $35.53 | $106.6K |
| Myszkowski Kenneth Allen | CFO | 2023-06-27 | SELL | 15,000 | $36.2 | $543K |
| GIVEN DOUGLAS B | Director | 2023-05-05 | SELL | 6,500 | $40.9 | $265.9K |
| Anzalone Christopher Richard | CEO | 2023-05-04 | SELL | 104,928 | $39.32 | $4125.8K |
| OLUKOTUN ADEOYE Y | Director | 2023-03-03 | SELL | 11,350 | $32.65 | $370.6K |
| GIVEN DOUGLAS B | Director | 2023-02-27 | SELL | 875 | $32.62 | $28.5K |
| Waddill William D. | Director | 2023-01-09 | SELL | 3,200 | $30 | $96K |
| O'Brien Patrick | COO and General Counsel | 2023-01-05 | SELL | 15,000 | $37.39 | $560.9K |
| Hamilton James C | Chief Discovery/Trans Medicine | 2023-01-05 | SELL | 13,803 | $37.4 | $516.2K |
| O'Brien Patrick | COO and General Counsel | 2023-01-03 | SELL | 17,500 | $38.33 | $670.8K |
| Hamilton James C | Chief Discovery/Trans Medicine | 2023-01-03 | SELL | 10,338 | $38.38 | $396.8K |
| Myszkowski Kenneth Allen | CFO | 2022-12-29 | SELL | 30,625 | $40 | $1225K |
| San Martin Javier | Chief Medical Officer | 2022-11-21 | SELL | 19,500 | $29.99 | $584.8K |
| Anzalone Christopher Richard | CEO | 2022-02-11 | SELL | 146,388 | $51.91 | $7599K |
| O'Brien Patrick | General Counsel | 2022-01-05 | SELL | 32,500 | $61.72 | $2005.9K |
| Myszkowski Kenneth Allen | CFO | 2022-01-05 | SELL | 40,000 | $61.7 | $2468K |
| Hamilton James C | Senior Vice President | 2022-01-05 | SELL | 25,625 | $64.57 | $1654.6K |
| Waddill William D. | Director | 2022-01-03 | SELL | 4,500 | $64.72 | $291.2K |
| OLUKOTUN ADEOYE Y | Director | 2022-01-03 | SELL | 4,050 | $64.75 | $262.2K |
| De Backer Marianne | Director | 2022-01-03 | SELL | 4,500 | $64.71 | $291.2K |
| PERRY MICHAEL S | Director | 2022-01-03 | SELL | 4,500 | $64.71 | $291.2K |
| GIVEN DOUGLAS B | Director | 2021-12-28 | BUY | 655 | $66.37 | $43.5K |
| Ferrari Mauro | Director | 2021-12-28 | SELL | 3,400 | $66.82 | $227.2K |
| Anzalone Christopher Richard | CEO | 2021-12-15 | SELL | 60,000 | $67.56 | $4053.6K |
| San Martin Javier | Chief Medical Officer | 2021-11-19 | SELL | 19,500 | $69.31 | $1351.5K |
| Anzalone Christopher Richard | CEO | 2021-10-22 | SELL | 65,000 | $65.77 | $4275.1K |
| OLUKOTUN ADEOYE Y | Director | 2021-09-13 | SELL | 5,000 | $63.76 | $318.8K |
| GIVEN DOUGLAS B | Director | 2021-09-09 | SELL | 5,000 | $65.24 | $326.2K |
| De Backer Marianne | Director | 2021-06-24 | SELL | 5,000 | $89.85 | $449.3K |
| Hassard James | Chief Commercial Officer | 2021-06-22 | SELL | 3,625 | $89.22 | $323.4K |
| GIVEN DOUGLAS B | Director | 2021-06-22 | SELL | 4,500 | $89.21 | $401.4K |
| GIVEN DOUGLAS B | Director | 2021-02-22 | SELL | 1,125 | $88.73 | $99.8K |
| O'Brien Patrick | General Counsel | 2021-02-08 | SELL | 90,000 | $88.46 | $7961.4K |
| GIVEN DOUGLAS B | Director | 2021-01-15 | SELL | 3,000 | $83.28 | $249.8K |
| Hamilton James C | Senior Vice President | 2021-01-14 | SELL | 10,000 | $81.29 | $812.9K |
| Myszkowski Kenneth Allen | CFO | 2021-01-12 | SELL | 13,038 | $81.02 | $1056.3K |
| Hassard James | Chief Commercial Officer | 2021-01-07 | SELL | 15,625 | $75 | $1171.9K |
| O'Brien Patrick | General Counsel | 2021-01-06 | SELL | 25,000 | $72.41 | $1810.3K |
| Myszkowski Kenneth Allen | CFO | 2021-01-06 | SELL | 30,625 | $72.44 | $2218.5K |
| Hamilton James C | Senior Vice President | 2021-01-06 | SELL | 38,750 | $72.51 | $2809.8K |
| Waddill William D. | Director | 2021-01-04 | SELL | 3,750 | $76.08 | $285.3K |
| PERRY MICHAEL S | Director | 2021-01-04 | SELL | 4,000 | $76.09 | $304.4K |
| GIVEN DOUGLAS B | Director | 2021-01-04 | SELL | 4,000 | $76.08 | $304.3K |
| GIVEN DOUGLAS B | Director | 2020-12-17 | SELL | 9,575 | $79.32 | $759.5K |
| Waddill William D. | Director | 2020-12-10 | SELL | 3,000 | $71.26 | $213.8K |
| Anzalone Christopher Richard | CEO | 2020-12-09 | SELL | 55,000 | $68.73 | $3780.2K |
| Bradshaw Curt | Chief Scientific Officer | 2020-11-20 | SELL | 31,250 | $69.06 | $2158.1K |
| San Martin Javier | Chief Medical Officer | 2020-11-19 | SELL | 19,500 | $69.39 | $1353.1K |
| Myszkowski Kenneth Allen | CFO | 2020-11-09 | SELL | 43,505 | $69.37 | $3017.9K |
| Anzalone Christopher Richard | CEO | 2020-10-23 | SELL | 100,000 | $58.21 | $5821K |
| Myszkowski Kenneth Allen | CFO | 2020-10-20 | SELL | 29,166 | $54.04 | $1576.1K |
| Ferrari Mauro | Director | 2020-10-09 | SELL | 10,000 | $48 | $480K |
| De Backer Marianne | Director | 2020-10-08 | BUY | 1,000 | $50.47 | $50.5K |
| Anzalone Christopher Richard | CEO | 2020-08-13 | SELL | 50,000 | $41.35 | $2067.5K |
| Anzalone Christopher Richard | CEO | 2020-06-25 | SELL | 100,000 | $38.81 | $3881K |
| De Backer Marianne | Director | 2020-06-15 | BUY | 4,000 | $33.56 | $134.2K |
| PERRY MICHAEL S | Director | 2020-05-12 | SELL | 36,000 | $35.83 | $1289.9K |
| Waddill William D. | Director | 2020-05-11 | SELL | 26,000 | $36.54 | $950K |
| GIVEN BRUCE D | COO | 2020-04-28 | SELL | 5,401 | $40 | $216K |
| GIVEN BRUCE D | COO | 2020-04-20 | SELL | 23,515 | $40 | $940.6K |
| GIVEN DOUGLAS B | Director | 2020-04-14 | SELL | 25,000 | $36.89 | $922.3K |
| Myszkowski Kenneth Allen | CFO | 2020-01-21 | SELL | 40,313 | $49.44 | $1993.1K |
| GIVEN BRUCE D | COO | 2020-01-06 | SELL | 35,613 | $60.13 | $2141.4K |
| O'Brien Patrick | General Counsel | 2020-01-06 | SELL | 14,625 | $60.12 | $879.3K |
| Myszkowski Kenneth Allen | CFO | 2020-01-06 | SELL | 20,000 | $60.11 | $1202.2K |
| Anzalone Christopher Richard | CEO | 2019-12-24 | SELL | 83,333 | $63.5 | $5291.6K |
| Anzalone Christopher Richard | CEO | 2019-12-13 | SELL | 183,333 | $67.15 | $12310.8K |
| Anzalone Christopher Richard | CEO | 2019-12-03 | SELL | 50,000 | $67.33 | $3366.5K |
| Myszkowski Kenneth Allen | CFO | 2019-11-01 | SELL | 37,884 | $40.85 | $1547.6K |
| Anzalone Christopher Richard | CEO | 2019-10-10 | SELL | 56,325 | $31.83 | $1792.8K |
| Anzalone Christopher Richard | CEO | 2019-09-25 | SELL | 20,000 | $28.25 | $565K |
| Anzalone Christopher Richard | CEO | 2019-09-24 | SELL | 112,650 | $28.54 | $3215K |
| PERRY MICHAEL S | Director | 2019-09-11 | SELL | 185,000 | $29.41 | $5440.9K |
| Ferrari Mauro | Director | 2019-06-26 | SELL | 17,756 | $27.61 | $490.2K |
| O'Brien Patrick | General Counsel | 2019-05-28 | SELL | 30,000 | $24.88 | $746.4K |
| Myszkowski Kenneth Allen | CFO | 2019-05-21 | SELL | 27,071 | $22 | $595.6K |
| Anzalone Christopher Richard | CEO | 2019-04-03 | SELL | 50,000 | $19.3 | $965K |
| GIVEN BRUCE D | COO | 2019-03-01 | SELL | 42,500 | $19.99 | $849.6K |
| GIVEN BRUCE D | COO | 2019-02-25 | SELL | 42,500 | $18.98 | $806.7K |
| Myszkowski Kenneth Allen | CFO | 2019-02-19 | SELL | 8,000 | $18 | $144K |
| GIVEN BRUCE D | COO | 2019-02-19 | SELL | 68,750 | $17.86 | $1227.9K |
| GIVEN BRUCE D | COO | 2019-02-12 | SELL | 242,834 | $16.04 | $3895.1K |
| GIVEN BRUCE D | COO | 2019-02-05 | SELL | 22,500 | $14.48 | $325.8K |
| GIVEN BRUCE D | COO | 2019-02-01 | SELL | 28,500 | $13.85 | $394.7K |
| GIVEN BRUCE D | COO | 2019-01-23 | SELL | 169,500 | $13.54 | $2295K |
| GIVEN DOUGLAS B | Director | 2019-01-22 | SELL | 3,000 | $13.58 | $40.7K |
| O'Brien Patrick | General Counsel | 2019-01-18 | SELL | 72,000 | $14.43 | $1039K |
| Myszkowski Kenneth Allen | CFO | 2019-01-17 | SELL | 81,875 | $14.55 | $1191.3K |
| Li Zhen | Snr. VP, Chem and Non-Clin Dev | 2019-01-14 | SELL | 40,500 | $14.34 | $580.8K |
| GIVEN BRUCE D | COO | 2019-01-14 | SELL | 42,666 | $14.4 | $614.4K |
| Waddill William D. | Director | 2019-01-11 | SELL | 8,500 | $14.77 | $125.5K |
| Myszkowski Kenneth Allen | CFO | 2019-01-02 | SELL | 8,333 | $11.98 | $99.8K |
| GIVEN BRUCE D | COO | 2019-01-02 | SELL | 20,000 | $11.98 | $239.6K |
| GIVEN DOUGLAS B | Director | 2018-12-27 | SELL | 3,000 | $12 | $36K |
| Anzalone Christopher Richard | CEO | 2018-12-19 | SELL | 90,000 | $13.92 | $1252.8K |
| Anzalone Christopher Richard | CEO | 2018-12-12 | SELL | 90,000 | $14.07 | $1266.3K |
| GIVEN DOUGLAS B | Director | 2018-11-23 | SELL | 3,000 | $12.74 | $38.2K |
| Anzalone Christopher Richard | CEO | 2018-11-09 | SELL | 81,500 | $14.39 | $1172.8K |
| Leone Peter Brian | VP, Strategic Bus. Initiatives | 2018-10-19 | SELL | 131,137 | $13.49 | $1769K |
| Myszkowski Kenneth Allen | CFO | 2018-09-06 | SELL | 45,000 | $19.34 | $870.3K |
| Anzalone Christopher Richard | CEO | 2018-09-04 | SELL | 164,834 | $14.45 | $2381.9K |
| Myszkowski Kenneth Allen | CFO | 2018-06-19 | SELL | 20,000 | $14.01 | $280.2K |
| Myszkowski Kenneth Allen | CFO | 2018-05-31 | SELL | 14,000 | $11 | $154K |
| GIVEN DOUGLAS B | Director | 2018-04-24 | SELL | 25,000 | $6.63 | $165.8K |
| Myszkowski Kenneth Allen | CFO | 2018-03-27 | SELL | 20,000 | $8 | $160K |
| Anzalone Christopher Richard | CEO | 2018-03-16 | SELL | 26,000 | $7.4 | $192.4K |
| Anzalone Christopher Richard | CEO | 2018-03-15 | SELL | 300,000 | $7.43 | $2229K |
| GIVEN BRUCE D | COO | 2018-03-05 | SELL | 20,000 | $6.73 | $134.6K |
| GIVEN BRUCE D | COO | 2018-01-01 | SELL | 20,000 | $3.69 | $73.8K |
| GIVEN DOUGLAS B | Director | 2016-10-14 | SELL | 12,000 | $6.72 | $80.6K |
| Myszkowski Kenneth Allen | CFO | 2016-08-23 | SELL | 20,000 | $8 | $160K |
| Myszkowski Kenneth Allen | CFO | 2016-08-23 | SELL | 20,000 | $8 | $160K |
| Myszkowski Kenneth Allen | CFO | 2015-12-30 | SELL | 23,347 | $6.13 | $143.1K |
| Lewis David L. | Chief Scientific Officer | 2015-01-05 | SELL | 15,000 | $8.01 | $120.2K |
| Anzalone Christopher Richard | President and CEO | 2014-10-15 | BUY | 16,000 | $6.32 | $101.1K |
| Anzalone Christopher Richard | President and CEO | 2014-10-15 | BUY | 16,000 | $6.32 | $101.1K |
| McKenney Charles | Director | 2014-10-01 | SELL | 2,500 | $14.7 | $36.8K |
| Lewis David L. | Chief Scientific Officer | 2014-09-30 | SELL | 15,000 | $15.02 | $225.3K |
| GIVEN DOUGLAS B | Director | 2014-09-26 | SELL | 2,000 | $15.24 | $30.5K |
| GIVEN DOUGLAS B | Director | 2014-08-15 | SELL | 5,000 | $13.9 | $69.5K |
| Myszkowski Kenneth Allen | CFO | 2014-08-15 | SELL | 40,000 | $14.02 | $560.8K |
| McKenney Charles | Director | 2014-06-09 | SELL | 22,000 | $14.32 | $315K |
| Myszkowski Kenneth Allen | CFO | 2014-02-12 | SELL | 16,000 | $18.77 | $300.3K |
| FRYKMAN EDWARD W | Director | 2014-02-07 | SELL | 3,148 | $15.98 | $50.3K |
| Lewis David L. | Chief Scientific Officer | 2014-01-02 | SELL | 15,000 | $10.29 | $154.4K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked